LISI ANNUAL REPORT 2009
A significant external
growth operation
LISI MEDICAL should be changing its
size and increasing its technical potential
in 2010. The LISI Group has announced
exclusive negotiations with the Stryker
Corporation with a view to acquiring
the manufacturing activity at the Stryker
Benoist Girard site, located in Hérouville
Saint-Clair, in France. The second part
of these negotiations concerns the
manufacture and supply of orthopaedic
components to Stryker molded over a
period of five years. The transaction could
be completed before the end of the first
half of 2010.
A market with great potential
With this strategic operation, which
should enable us to enter a market with
great potential, LISI MEDICAL will not
only be able to improve its production
capacities, but also to become a supplier
to an international leader in medical
technology. The proposed contract with
Stryker presents other major benefits for
LISI MEDICAL. It will give us unique access
to the world of molded components in
the reconstructive surgery sector and will
enable us to significantly increase our
market share in the United States, the
largest market for this segment.
Outlook for 2010
In a context of gradual recovery, which
remains to be confirmed, LISI MEDICAL’s
objectives will be to meet the requirements
of clients in the sector, to continue its
transformation in order to comply with
new regulatory requirements, while at the
same time maintaining growth, integrating
the Caen unit into the group, and restoring
post-crisis economic ratios to a satisfactory
level.
ISO 13485 QUALIFICATION FOR
FLEURIEUX-SUR-L’ARBRESLE
Quality and approval processes have
been emphasized at the Fleurieux-sur-
l’Arbresle site. ISO 13485 certification
was obtained in appropriate conditions.
Good operational management and
the capacity to approve processes have
been acknowledged several times by our
auditor clients.
ACQUISITION OF STRYKER
BENOIST-GIRARD IN PROGRESS
The Benoist-Girard site is in the process
of being acquired and employs about
250 people. This site, which is based
in Hérouville Saint-Clair and has been
fully owned by the Stryker Corporation
since 1998, produces a wide variety of
orthopaedic implants and instruments.
This acquisition would allow LISI
MEDICAL to strengthen its position as
a world-class contracting company
specialized in the manufacturing of
implants and ancillaries. The purchase
includes a contract to supply Stryker, a
world leader in medical technology.
HIGHLIGHTS
45
